For one, branded GLP-1 medications come with steep price tags, even for patients with insurance, which could alienate Hims cost-conscious customer base
For those initiating GLP-1 therapy in 2021, 33% were persistent, while in the first quarter of 2024, 63% of new initiators were persistent
Concerns regarding a potential association between GLP-1 receptor agonists, including Ozempic, and pancreatic cancer have emerged from both preclinical studies and post-marketing surveillance reports
Administration of Subretinal Therapies Requiring Vitrectomy (APC 1563) Effective January 1, 2021, CMS established HCPCS code C9770 (Vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agent) and assigned it to a New Technology APC based on the geometric mean cost of CPT code 67036 (Vitrectomy, mechanical, pars plana approach) due to similar resource utilization